Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,242 | 5,167 | 4,085 | 6,036 | 6,630 |
| Marketable Securities | 3,500 | 5,500 | 8,000 | 8,000 | N/A |
| TOTAL | $8,007 | $10,978 | $12,517 | $14,754 | $6,981 |
| Non-Current Assets | |||||
| PPE Net | 149 | 163 | 162 | 181 | 170 |
| Other Non-Current Assets | 18 | 18 | 18 | 18 | 18 |
| TOTAL | $167 | $181 | $180 | $199 | $188 |
| Total Assets | $8,174 | $11,159 | $12,697 | $14,953 | $7,169 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 281 | 1,163 | 222 | 635 | 459 |
| Accrued Expenses | 940 | 1,106 | 1,443 | 1,187 | 1,097 |
| TOTAL | $1,221 | $2,269 | $1,665 | $1,822 | $1,556 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,221 | $2,269 | $1,665 | $1,822 | $1,556 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 0 | 65,349 | 65,349 | 64,949 | 36,160 |
| Common Shares | 1 | 1 | 6 | 6 | 3 |
| Retained earnings | -59,336 | -57,105 | -54,489 | -51,993 | -49,827 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 3,106 |
| TOTAL | $6,953 | $8,890 | $11,032 | $13,131 | $5,613 |
| Total Liabilities And Equity | $8,174 | $11,159 | $12,697 | $14,953 | $7,169 |